• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

fraudulent

  1. State of Mid-Atlantic Labs

    With all the talk on here about Ammon, Medcreen, Clarity, ADL, SDX/Mako, RDX/Xeron and many other NE labs, is there any future in the lab industry? NY is a mess with Enzo selling to LC, Xeron being sold, (Sherman Abrahms, all Russina owned labs & Lenco pay to play business model, BRL being BRL...
  2. Ammon Labs is better than ever!

    I am thrilled to share some exciting news about Ammon Labs! Ammon Labs has long been recognized for its unwavering commitment to providing top-notch service to our valued customers for over 23 years! We take immense pride in our ability to deliver accurate and timely results, ensuring peace of...
  3. Progenity part 2..?

    I’m struggling to save face with a few of my accounts due to our billing practices. After digging deeper into cases, turns out these patients were wrongfully billed. Providers and patients want answers. Management is feeding me general blanket statements to get by but it’s raised a lot of moral...
  4. Ammon Labs Charity Scam

    Anyone see the Ammon Labs & Ammon Foundation Charity scam? Ammon set up a 501c non-profit to give out scholarships to people in recovery. I hear they use it for different reasons. Can anyone say illegal?